Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Asia Pacific Gastroenterology and Digestive Institute (APGDI) is a specialized healthcare provider based in Singapore, focusing on the comprehensive diagnosis and treatment of gastrointestinal and liver diseases. The institute offers a wide range of clinical services, including diagnostic and therapeutic endoscopy, colonoscopy, and the management of complex digestive disorders such as inflammatory bowel disease and hepatitis. APGDI is composed of a team of experienced gastroenterologists and hepatologists who provide personalized care and advanced medical interventions. Operating out of premier medical hubs like Gleneagles Hospital and Mount Elizabeth Novena, the center serves both local and international patients with an emphasis on clinical excellence and patient-centric outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Apgdi.